Headed to #EHA2026? Christa Gott and Hollie Hongosh Knight will be in Stockholm connecting with leaders across hematology to discuss what’s next in strategy, engagement, and impact. To schedule time with the Vaniam Group team, email partnership@vaniamgroup.com. #EHA26 #Hematology #VaniamGroup #VaniamIntelligence

Bio Ascend and Vaniam Group take on leadership of iwNHL and iwMyeloma, advancing the next chapter of two globally recognized hematologic oncology workshops. Read the full announcement: loom.ly/6M4VmHc #HematologicOncology #Lymphoma #MultipleMyeloma #Oncology #BioAscend #VaniamGroup

We’re here at ASCO. The conversations happening across McCormick Place are exactly why we built Vaniam Intelligence. The data. The insights. The challenge of turning strategy into aligned action across medical affairs and commercial teams. If that sounds like your week in Chicago, stop by Booth 30147. We’re running live demos throughout the meeting and would love to show you what Vaniam Intelligence can do for your oncology brand. #ASCO2026 #Oncology #VaniamIntelligence

At #ASCO26, the headlines will move fast. Vaniam Intelligence helps uncover what sits beneath them. As we continue #AnticipatingASCO2026, Eric Redline, Vice President of Product Management at Vaniam Group, shares how patterns in the evidence can signal where the real opportunity is, why it matters now, and how teams can move forward with greater clarity. Visit us at Booth #30147 to see Vaniam Intelligence in action, or connect with us at partnership@vaniamgroup.com. #ASCO2026 #VaniamIntelligence #VaniamGroup #Oncology

Built over a decade with the oncology community we serve. Come find us at #ASCO26 this week. #oncology #curioscience #vaniamintelligence

Snapshots tell you where the market is. Curio tells you where it's moving, and why. At #ASCO26, Kraig Steubing will be in the conversations where oncology strategy forms, the questions HCPs are working through, the debates behind the data, and the shifts that show up in clinic long before they show up in guidelines. Every one of those questions and decisions compounds inside Curio. Find Kraig at Booth 30147 in Chicago or connect at partnership@vaniamgroup.com #AnticipatingASCO2026 #Oncology #VaniamIntelligence #CurioScience

Every year at ASCO, the same thing happens. Pivotal data lands. Clinical teams parse it through one lens. Medical through another. Commercial is on a flight home Tuesday night trying to make sense of it all before Wednesday morning. What we kept seeing wasn't a data problem. The data is there. What's missing is the synthesis and the tools to plan. The connective tissue between what the field saw at the podium and what the franchise does about it. Vaniam Intelligence is what we built for that gap. Four of our products will be on demo at ASCO: → Sphere™ · comprehensive HCP intelligence → Horizon™ · continuous competitive intelligence → Convene™ · customized congress engagement → Explore™ · synthesized pharma intelligence We'll be in Chicago at Booth 30147. If this resonates with what you're navigating, connect with us at partnership@vaniamgroup.com. #ASCO26 #VaniamGroup #Oncology #VaniamIntelligence

At ASCO, the science is the headline. The real work happens in the margins. As Hollie Knight, MBA puts it: anticipating needs, getting the details right, and making space for the conversations that matter. That’s the #VaniamDifference. Join us at #ASCO26 in Chicago. Stop by the #VaniamGroup Booth 30147 or schedule time with our team at partnership@vaniamgroup.com. #AnticipatingASCO2026 #Oncology #VaniamIntelligence #CurioScience

At #ASCO, the narrative moves fast. Your strategy has to move faster. As part of #AnticipatingASCO2026, Steve Tulk, Chief Technology Officer at Vaniam Group, shares why live intelligence is essential for staying ahead of shifting conversations, emerging data, and real-time strategic decision-making. Heading to #ASCO2026? Connect with us: partnership@vaniamgroup.com #VaniamIntelligence #CurioScience #VaniamGroup

Supporting #WomenLeadersInOncology means showing up for the people shaping what’s next in cancer care—especially as we head into ASCO 2026. WLO brings senior oncology leaders together to connect, share perspectives, and help move the field forward. Ready to make an impact? Explore partnership opportunities: loom.ly/aFvnPbs #WLO #OncologyLeadership #ASCO2026 #VaniamGroup #CancerResearch

Transformative science is only the beginning. As Robert L. Coleman, MD, FACOG, FACS shares, #ASCO2026 will pressure-test how teams turn emerging data into real-world strategy. Heading to #ASCO? Let’s connect: partnership@vaniamgroup.com #AnticipatingASCO2026 #Oncology #Biopharma #VaniamGroup

We’ve spent twenty years building one thing: the deepest oncology intelligence in the industry. Today we’re introducing the new Vaniam Group — the integrated oncology organization built for what’s next. One company. One foundation. Continuously strengthening. vaniamgroup.com #VaniamGroup #CurioScience #VaniamIntelligence #Oncology

We’ve been thinking a lot about what it means to use AI responsibly in oncology and rare disease.  Not responsibly in the compliance sense. Responsibly in the sense the science is right, the context is right, and the people on the other end of the decision trust what they’re reading. That’s a harder problem than building a fast model. It’s a people problem. And at Vaniam Group, we’ve been working on the people side of it for 19 years. The AI part is new. The trust it runs on isn’t. Learn more: loom.ly/GBTzm #Oncology #RareDisease #AI #VaniamGroup #Biopharma #CurioScience #VaniamIntelligence

SGO 2026, distilled. Vaniam Group CMO Robert L. Coleman, MD, FACOG, FACS and Kathleen N. Moore, MD, MS, FASCO break down what mattered most for #gynoncology practice, ovarian, endometrial, and cervical, on the latest episode of Podium Perspectives. HCPs and APPs, join Our Network to stay informed on the latest updates across oncology. 📷 Join Our Network: loom.ly/xGPP20o 📷 Listen Now: loom.ly/KekaKog Powered by Vaniam Group. The views expressed by the hosts and guests are their own and do not necessarily represent those of their respective institutions or employers. #SGOAM26 #VaniamGroup #PodiumPerspectives #CurioScience #GynecologicOncology #Oncology

On World Health Day, we think about the distance between data and decisions, and what it costs when that gap is too wide. Vaniam Intelligence exists to close it, by turning complex oncology evidence into clear, reliable insight that medical and commercial teams can act on with confidence. Curiosity welcome. Reach us at partnership@vaniamgroup.com. #WorldHealthDay #VaniamIntelligence #OncologyIntelligence #VaniamGroup #dataintelligence

The gynecologic oncology community gathers at #SGOmtg this week, and we'll be there! Vaniam Group's onsite team, led by Chief Medical Officer Robert L. Coleman, MD, FACOG, FACS, is looking forward to the conversations that shape how we understand and advance this field. If you're attending and want to connect, reach out at partnership@vaniamgroup.com. #SGO2026 #GynecologicOncology #MedicalCommunications #VaniamGroup #Curio

During #MultipleMyelomaAwarenessMonth, trust comes into focus: in the data we rely on, the insights we draw from it, and the partners we choose. At Vaniam Group, trusted insight enables confident, informed decisions.

Exciting news at Vaniam Group: Cherie Myatt has been appointed Interim President, bringing founder insight, enterprise leadership, and a deep commitment to building what’s next. Full press release: loom.ly/Wg5UCzQ #VaniamGroup #LifeSciences #HealthcareLeadership #Oncology #RareDisease #PatientEngagement

As we approach #ASCO2026, Women Leaders in Oncology and Allies returns to Chicago on June 1, 2026! We gather to elevate voices and strengthen the leadership that's shaping what’s next in oncology. HCP registration is now open: loom.ly/IxQSDUs Sponsorship & partnership opportunities: loom.ly/i61dF8Y #WomenLeadersInOncology #OncologyLeadership #ASCO26 #VaniamGroup #WLO

What stood out at #ASCOGI2026? This year’s symposium surfaced several meaningful data updates across GI oncology, offering some fresh viewpoints on evolving treatment approaches. In the newest episode of Vaniam Group's Podium Perspectives, Dr. Rachna Shroff and Dr. Aparna Parikh highlight the studies and themes that shaped this year’s meeting, providing a clear look at where the field is continuing to advance.  Listen now:  Spotify: loom.ly/h8raKF8  Apple: loom.ly/3qFgAy0  YouTube: loom.ly/4RPILC0 #ASCOGI #GICancer #Oncology #CancerResearch #PodiumPerspectives #VaniamGroup